| Year |
Citation |
Score |
| 2006 |
James CA, Hadley DW, Holtzman NA, Winkelstein JA. How does the mode of inheritance of a genetic condition influence families? A study of guilt, blame, stigma, and understanding of inheritance and reproductive risks in families with X-linked and autosomal recessive diseases. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 8: 234-42. PMID 16617244 DOI: 10.1097/01.Gim.0000215177.28010.6E |
0.556 |
|
| 2005 |
Holtzman NA, Bernhardt BA, Mountcastle-Shah E, Rodgers JE, Tambor E, Geller G. The quality of media reports on discoveries related to human genetic diseases. Community Genetics. 8: 133-44. PMID 16113530 DOI: 10.1159/000086756 |
0.31 |
|
| 2004 |
Rappaport KM, Forrest CB, Holtzman NA. Adoption of liquid-based cervical cancer screening tests by family physicians and gynecologists. Health Services Research. 39: 927-47. PMID 15230935 DOI: 10.1111/J.1475-6773.2004.00265.X |
0.725 |
|
| 2004 |
Holtzman NA. Eugenics and genetic testing. Science in Context. 11: 397-417. PMID 15168670 DOI: 10.1017/S0269889700003100 |
0.326 |
|
| 2004 |
Holtzman NA. Expanded Screening of Newborns for Genetic Disorders—Reply Jama. 291: 820-821. DOI: 10.1001/Jama.291.7.821-A |
0.355 |
|
| 2003 |
Holtzman NA. Ethical aspects of genetic testing in the workplace. Community Genetics. 6: 136-8. PMID 15237197 DOI: 10.1159/000078160 |
0.404 |
|
| 2003 |
James CA, Holtzman NA, Hadley DW. Perceptions of reproductive risk and carrier testing among adolescent sisters of males with chronic granulomatous disease. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics. 119: 60-9. PMID 12704639 DOI: 10.1002/Ajmg.C.10007 |
0.559 |
|
| 2003 |
Doksum T, Bernhardt BA, Holtzman NA. Does knowledge about the genetics of breast cancer differ between nongeneticist physicians who do or do not discuss or order BRCA testing? Genetics in Medicine : Official Journal of the American College of Medical Genetics. 5: 99-105. PMID 12644779 DOI: 10.1097/01.Gim.0000055198.63593.32 |
0.755 |
|
| 2002 |
Chase GA, Geller G, Havstad SL, Holtzman NA, Bassett SS. Physicians' propensity to offer genetic testing for Alzheimer's disease: results from a survey. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 4: 297-303. PMID 12172396 DOI: 10.1097/00125817-200207000-00008 |
0.351 |
|
| 2002 |
Starfield B, Holtzman NA, Roland MO, Sibbald B, Harris R, Harris H. Primary care and genetic services. Health care in evolution. European Journal of Public Health. 12: 51-6. PMID 11968521 DOI: 10.1093/Eurpub/12.1.51 |
0.316 |
|
| 2002 |
Geller G, Bernhardt BA, Holtzman NA. The media and public reaction to genetic research. Jama. 287: 773. PMID 11851549 DOI: 10.1001/Jama.287.6.773-Jms0213-3-1 |
0.356 |
|
| 2001 |
Doksum T, Bernhardt BA, Holtzman NA. Carrier screening for cystic fibrosis among Maryland obstetricians before and after the 1997 NIH Consensus Conference. Genetic Testing. 5: 111-6. PMID 11551096 DOI: 10.1089/109065701753145565 |
0.743 |
|
| 2001 |
Holtzman NA. Riding the Range (of Genetics) Cell. 105: 324-325. DOI: 10.1016/S0092-8674(01)00354-3 |
0.37 |
|
| 2000 |
Sotos JG, Rienhoff H.Y. J, Block GD, Aulisio MP, Khoury MJ, Ference BA, Chauhan MS, Izumo S, Holtzman NA, Marteau TM. Will genetics revolutionize medicine? [3] (multiple letters) New England Journal of Medicine. 343: 1496-1498. PMID 11184467 DOI: 10.1056/Nejm200011163432014 |
0.327 |
|
| 2000 |
Mountcastle-Shah E, Holtzman NA. Primary care physicians' perceptions of barriers to genetic testing and their willingness to participate in research. American Journal of Medical Genetics. 94: 409-16. PMID 11050628 DOI: 10.1002/1096-8628(20001023)94:5<409::Aid-Ajmg13>3.0.Co;2-U |
0.372 |
|
| 2000 |
Holtzman NA, Marteau TM. Will genetics revolutionize medicine? The New England Journal of Medicine. 343: 141-4. PMID 10891526 DOI: 10.1056/Nejm200007133430213 |
0.349 |
|
| 2000 |
Tambor ES, Bernhardt BA, Geller G, Helzlsouer KJ, Doksum T, Holtzman NA. Should women at increased risk for breast and ovarian cancer be randomized to prophylactic surgery? An ethical and empirical assessment. Journal of Women's Health & Gender-Based Medicine. 9: 223-33. PMID 10787220 DOI: 10.1089/152460900318434 |
0.727 |
|
| 1999 |
Holtzman NA. The UK's policies on genetic testing for late-onset disorders. Community Genetics. 2: 43-5. PMID 11658107 DOI: 10.1159/000016183 |
0.357 |
|
| 1999 |
Myers MF, Doksum T, Holtzman NA. Genetic services for common complex disorders: surveys of health maintenance organizations and academic genetic centers. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 1: 272-85. PMID 11258629 DOI: 10.1097/00125817-199909000-00006 |
0.731 |
|
| 1999 |
Holtzman NA. Are genetic tests adequately regulated? Science (New York, N.Y.). 286: 409. PMID 10577197 DOI: 10.1126/Science.286.5439.409 |
0.389 |
|
| 1999 |
Eisinger F, Geller G, Burke W, Holtzman NA. Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer. The Lancet. 353: 919-920. PMID 10094000 DOI: 10.1016/S0140-6736(98)07516-3 |
0.314 |
|
| 1999 |
Holtzman NA. Promoting Safe and Effective Genetic Tests in the United States: Work of the Task Force on Genetic Testing Clinical Chemistry. 45: 732-738. DOI: 10.1093/Clinchem/45.5.732 |
0.337 |
|
| 1998 |
Holtzman NA. The UK's policy on genetic testing services supplied direct to the public -- two spheres and two tiers. Community Genetics. 1: 49-52. PMID 11660582 DOI: 10.1159/000016135 |
0.385 |
|
| 1998 |
Evers-Kiebooms G, Denayer L, Welkenhuysen M, Wildhagen MF, Os TAMv, Polder JJ, Kate LPt, Habbema JDF, Hayflick SJ, Eiff MP, Decruyenaere M, Modell B, Kuliev A, Jaber L, Halpern GJ, ... ... Holtzman NA, et al. Code of Practice on Human Genetic Testing Services Supplied Direct to the Public Public Health Genomics. 1: 48-48. PMID 11660581 DOI: 10.1159/000016134 |
0.314 |
|
| 1998 |
James C, Geller G, Bernhardt BA, Docksum T, Holtzman NA. Are practicing and future physicians prepared to obtain informed consent? The case of genetic testing for susceptibility to breast cancer. Community Genetics. 1: 203-12. PMID 11658004 DOI: 10.1159/000016165 |
0.6 |
|
| 1998 |
Geller G, Bernhardt BA, Doksum T, Helzlsouer KJ, Wilcox P, Holtzman NA. Decision-making about breast cancer susceptibility testing: how similar are the attitudes of physicians, nurse practitioners, and at-risk women? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 2868-76. PMID 9704741 DOI: 10.1200/Jco.1998.16.8.2868 |
0.739 |
|
| 1998 |
Bernhardt BA, Geller G, Doksum T, Larson SM, Roter D, Holtzman NA. Prenatal genetic testing: content of discussions between obstetric providers and pregnant women. Obstetrics and Gynecology. 91: 648-55. PMID 9572205 DOI: 10.1016/S0029-7844(98)00011-8 |
0.744 |
|
| 1998 |
Holtzman NA, Shapiro D. Genetic testing and public policy. Bmj (Clinical Research Ed.). 316: 852-6. PMID 9549463 DOI: 10.1136/Bmj.316.7134.852 |
0.416 |
|
| 1998 |
Holtzman NA. Bringing genetic tests into the clinic. Hospital Practice (1995). 33: 107-12, 115-6, 121-2. PMID 9464234 DOI: 10.1080/21548331.1998.11443623 |
0.377 |
|
| 1998 |
Leòn MPd, Anti M, Pedroni M, Bellacosa A, Percesepe A, Covino M, Benatti P, Tin LD, Roncucci L, Valentini M, Boiocchi M, Neri G, Allen HJ, Briceno CA, Piver MS, ... ... Holtzman NA, et al. Contents Vol. 1, 1998 Public Health Genomics. 1: 263-263. DOI: 10.1159/000016174 |
0.715 |
|
| 1998 |
Leòn MPd, Anti M, Pedroni M, Bellacosa A, Percesepe A, Covino M, Benatti P, Tin LD, Roncucci L, Valentini M, Boiocchi M, Neri G, Allen HJ, Briceno CA, Piver MS, ... ... Holtzman NA, et al. Subject Index Vol. 1, 1998 Public Health Genomics. 1: 261-262. DOI: 10.1159/000016173 |
0.71 |
|
| 1997 |
Bernhardt BA, Geller G, Strauss M, Helzlsouer KJ, Stefanek M, Wilcox PM, Holtzman NA. Toward a model informed consent process for BRCA1 testing: a qualitative assessment of women's attitudes. Journal of Genetic Counseling. 6: 207-22. PMID 11656642 DOI: 10.1023/A:1025668320403 |
0.359 |
|
| 1997 |
Holtzman NA. Testing for genetic susceptibility: what you see is not what you get. Accountability in Research. 5: 95-101. PMID 11654816 DOI: 10.1080/08989629708573900 |
0.359 |
|
| 1997 |
Cho MK, Arruda M, Holtzman NA. Educational material about genetic tests: Does it provide key information for patients and practitioners? American Journal of Medical Genetics. 73: 314-320. PMID 9415691 DOI: 10.1002/(Sici)1096-8628(19971219)73:3<314::Aid-Ajmg16>3.0.Co;2-M |
0.375 |
|
| 1997 |
Holtzman NA, Murphy PD, Watson MS, Barr PA. Predictive genetic testing: from basic research to clinical practice. Science (New York, N.Y.). 278: 602-5. PMID 9381169 DOI: 10.1126/Science.278.5338.602 |
0.344 |
|
| 1997 |
Holtzman NA, Andrews LB. Ethical and legal issues in genetic epidemiology. Epidemiologic Reviews. 19: 163-74. PMID 9360913 DOI: 10.1093/Oxfordjournals.Epirev.A017939 |
0.383 |
|
| 1997 |
Geller G, Strauss M, Bernhardt BA, Holtzman NA. "Decoding" Informed Consent Insights from Women regarding Breast Cancer Susceptibility Testing The Hastings Center Report. 27: 28. DOI: 10.2307/3527625 |
0.418 |
|
| 1996 |
James CA, Bernhardt BA, Doksum T, Holtzman NA, Geller G. Attitudes toward BRCA1 testing among physicians and medical students. American Journal of Human Genetics. 59: A7. PMID 11644837 |
0.741 |
|
| 1996 |
Holtzman NA. The attempt to pass the Genetic Privacy Act in Maryland. The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics. 23: 367-70. PMID 8715057 DOI: 10.1111/J.1748-720X.1995.Tb01379.X |
0.325 |
|
| 1996 |
Geller G, Bernhardt BA, Helzlsouer K, Holtzman NA, Stefanek M, Wilcox PM. Informed consent and BRCA1 testing. Nature Genetics. 11: 364. PMID 7493013 DOI: 10.1038/Ng1295-364 |
0.315 |
|
| 1995 |
Geller G, Holtzman NA. A Qualitative Assessment of Primary Care Physicians' Perceptions about the Ethical and Social Implications of Offering Genetic Testing Qualitative Health Research. 5: 97-116. DOI: 10.1177/104973239500500107 |
0.39 |
|
| 1994 |
Faden RR, Tambor ES, Chase GA, Geller G, Hofman KJ, Holtzman NA. Attitudes of physicians and genetics professionals toward cystic fibrosis carrier screening. American Journal of Medical Genetics. 50: 1-11. PMID 8160745 DOI: 10.1002/Ajmg.1320500102 |
0.429 |
|
| 1994 |
Geller G, Tambor ES, Bernhardt BA, Chase GA, Hofman KJ, Faden RR, Holtzman NA. Physicians' attitudes toward disclosure of genetic information to third parties. The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics. 21: 238-40. PMID 8130834 DOI: 10.1111/J.1748-720X.1993.Tb01246.X |
0.341 |
|
| 1994 |
Collins FS, Benjamin LJ, Botstein D, Cox JR, Davidson N, Gray JW, Housman DE, Holtzman N, Jamison KR, Rothstein R, Smith DC, Smith LM, Spence MA, Tilghman SM. Statement on Use of DNA Testing for Presymptomatic Identification of Cancer Risk Jama: the Journal of the American Medical Association. 271: 785. PMID 8114217 DOI: 10.1001/Jama.1994.03510340075038 |
0.36 |
|
| 1994 |
Holtzman NA. Benefits and risks of emerging genetic technologies: the need for regulation Clinical Chemistry. 40: 1652-1657. DOI: 10.1093/Clinchem/40.8.1652 |
0.374 |
|
| 1993 |
Holtzman NA. Primary care physicians as providers of frontline genetic services. Fetal Diagnosis and Therapy. 213-9. PMID 8512648 DOI: 10.1159/000263890 |
0.355 |
|
| 1993 |
Hofman KJ, Tambor ES, Chase GA, Geller G, Faden RR, Holtzman NA. Physicians' knowledge of genetics and genetic tests. Academic Medicine : Journal of the Association of American Medical Colleges. 68: 625-32. PMID 8352875 DOI: 10.1097/00001888-199308000-00013 |
0.39 |
|
| 1993 |
Geller G, Tambor ES, Chase GA, Holtzman NA. Measuring physicians' tolerance for ambiguity and its relationship to their reported practices regarding genetic testing. Medical Care. 31: 989-1001. PMID 8231339 DOI: 10.1097/00005650-199311000-00002 |
0.386 |
|
| 1992 |
Holtzman NA. The diffusion of new genetic tests for predicting disease. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 6: 2806-12. PMID 1634043 DOI: 10.1096/Fasebj.6.10.1634043 |
0.42 |
|
| 1991 |
Geller G, Holtzman NA. Implications of the human genome initiative for the primary care physician. Bioethics. 5: 318-25. PMID 11653952 DOI: 10.1111/J.1467-8519.1991.Tb00172.X |
0.398 |
|
| 1991 |
Holtzman NA. What drives neonatal screening programs? The New England Journal of Medicine. 325: 802-4. PMID 1870654 DOI: 10.1056/Nejm199109123251109 |
0.306 |
|
| 1990 |
Holtzman NA. Risk estimates and genetic screening as public policy. World Review of Nutrition and Dietetics. 63: 250-65. PMID 2197803 DOI: 10.1159/000418513 |
0.305 |
|
| 1990 |
Holtzman NA. Prenatal screening: when and for whom? Journal of General Internal Medicine. 5: S42-6. PMID 2146372 DOI: 10.1007/Bf02600840 |
0.346 |
|
| 1986 |
Chase GA, Faden RR, Holtzman NA, Chwalow AJ, Leonard CO, Lopes C, Quaid K. Assessment of risk by pregnant women: implications for genetic counseling and education. Social Biology. 33: 57-64. PMID 3775442 DOI: 10.1080/19485565.1986.9988622 |
0.303 |
|
| 1985 |
Grossman LK, Holtzman NA, Charney E, Schwartz AD. Neonatal screening and genetic counseling for sickle cell trait. American Journal of Diseases of Children (1960). 139: 241-4. PMID 3976605 DOI: 10.1001/Archpedi.1985.02140050035016 |
0.354 |
|
| 1985 |
Faden RR, Chwalow AJ, Orel-Crosby E, Holtzman NA, Chase GA, Leonard CO. What participants understand about a maternal serum alpha-fetoprotein screening program. American Journal of Public Health. 75: 1381-4. PMID 2415009 DOI: 10.2105/Ajph.75.12.1381 |
0.331 |
|
| 1984 |
Farfel MR, Holtzman NA. Education, consent, and counseling in sickle cell screening programs: report of a survey. American Journal of Public Health. 74: 373-5. PMID 6703168 DOI: 10.2105/Ajph.74.4.373 |
0.31 |
|
| 1982 |
Faden R, Chwalow AJ, Holtzman NA, Horn SD. A survey to evaluate parental consent as public policy for neonatal screening. American Journal of Public Health. 72: 1347-52. PMID 7137431 DOI: 10.2105/Ajph.72.12.1347 |
0.302 |
|
| 1980 |
Holtzman NA. Public interest in genetics and genetics in the public interest. American Journal of Medical Genetics. 5: 383-9. PMID 7395918 DOI: 10.1002/Ajmg.1320050409 |
0.319 |
|
| 1973 |
Holtzman NA. Prevention of retardation of genetic origin. Pediatric Clinics of North America. 20: 151-8. PMID 4577325 DOI: 10.1016/S0031-3955(16)32816-4 |
0.361 |
|
| Show low-probability matches. |